Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Trade agreements with stiff intellectual property protection requirements combined with buyouts of India’s top generics makers by multinationals threaten to deny affordable medicines to millions of poor. The cost of essential medicines is a major barrier to healthcare, writes LATHA JISHNU. But the Indian government is doing little to control …
In an ideal market economy competition lowers prices of consumer goods. It is just the opposite in the case of pharmaceutical products. More expensive brands sell more. Take Cyclovir, an ointment for treating skin infection caused by herpes. Its therapy cost (cost of one course) is Rs 812, while a …
Patients visiting public health centres in Nagaur district in central Rajasthan these days rarely buy branded drugs. Doctors direct them to the government- run generic medicine stores (GMS) where quality drugs are available at low cost. The district administration of Nagaur has managed to free the public health system from …
Bindeshwari, a scrap dealer in Punjab’s Ludhiana district, was asked to buy Cefzy-250 by the doctor treating his wife. She had delivered a baby in the government civil hospital in June-end. The chemist at the hospital’s Jan Aushadhi Store gave Bindeshwari Ceftazidime, a generic version of Cefzy- 250; both drugs …
MANY diabetics go through the pain of injecting themselves with insulin at least twice a day. The number of times they need to prick themselves to manage their blood sugar level can go up to 120 a month. The fear of pricking themselves often leads to noncompliance, making patients prone …
Ramya KannanCHENNAI: On the day his research article (co-authored with Timothy Walsh) in The Lancet on the New Delhi metallo-beta-lactamase created a stir in the medical community in two continents, Karthikeyan Kumarasamy was honoured at home.Madras University Vice-Chancellor G. Thiruvasagam feted Mr. Karthikeyan, a research student at the A.L. Mudaliar …
Aarti DharNEW DELHI: India has reacted strongly to a study linking a multiple drug-resistant superbug detected in Britain to India and said the bacteria are not a public health threat.It said Indian hospitals were safe as a number of such bacteria survived in nature and were reported from several other …
HEALTHCARE activists plan to take union health ministry and the chemical & fertilizers ministry to the Supreme Court (SC) for failing to regulate prices of essential drugs, seven years after the apex court asked them to do so.
JAIPUR: In a unique blend of traditional concepts and scientific aspects of medicine, a newly set up modern Unani health centre here is offering authentic, time-tested treatment systems to patients of serious diseases who have lost hopes from prolonged therapies of other medicinal streams.
The parliamentary standing committee on health and family welfare has slammed the health ministry for failing to take enough steps to restart the manufacture of vaccines in the three major public sector vaccine manufacturing units and hence raising the costs of the Universal Immunization Programme. The standing committee referred to …
Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-?-lactamase 1 (NDM-1) are potentially a major global health problem. The researchers investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK.Note: This research paper is available free online after registration to the journal Lancet Infectious …
Chennai: The Government of India has incurred a loss of more than Rs 116 crore by keeping three public sector vaccine labs closed for two years, government audits and RTI applications have revealed. While the government had to spend an additional Rs 40 crore to purchase BCG, DPT and TT …
LUPIN Limited and Ranbaxy Laboratories along with its parent company Daiichi Sankyo have slapped patent infringement charges against each other to stop one another from launching low-cost versions of their respective original drugs in the US. Last Wednesday, Lupin sued Ranbaxy after the latter sought American drug regulator
New Delhi: The parliamentary standing committee on health and family welfare has suggested measures like increasing the number of drugs under price control, a blanket cap on profit margins and promoting the use of generic drugs to make drugs more affordable and accessible to the common man. In a report …
From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history. A decade ago, the compound available only from the sweet wormwood plant Artemisia annua
